跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
MOZOBIL plerixafor 20 mg/mL solution for injection, type I clear glass vial - TGA Drug Approval Details
Approvals
/
TGA
/
MOZOBIL plerixafor 20 mg/mL solution for injection, type I clear glass vial
Approved
STANDARD
MOZOBIL plerixafor 20 mg/mL solution for injection, type I clear glass vial
Sanofi-Aventis Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
c4f0df48953357b5
Company
Sanofi-Aventis Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
c4f0df48953357b5
Product Name
MOZOBIL plerixafor 20 mg/mL solution for injection, type I clear glass vial
Artg Id
158423
Artg Name
MOZOBIL plerixafor 20 mg/mL solution for injection 1.2 mL vial
Sponsor
Sanofi-Aventis Australia Pty Ltd
Company Detail Path
/organization/sanofi-aventis-australia-pty-ltd
Artg Date
2010-05-31
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
https://medical-cdn.nocode.com/drug_tga/b36d39b1b368c742a55b26c23db0e67b.pdf
Product Information
https://medical-cdn.nocode.com/drug_tga/5b37db4f00182456fe267d2179e37c0c.pdf
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
c4f0df48953357b5
Type
Standard
Back to TGA Approvals